{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T13:30:20Z","timestamp":1771939820600,"version":"3.50.1"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.ejphar.2025.177686","type":"journal-article","created":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T06:24:10Z","timestamp":1745648650000},"page":"177686","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Edaravone protects against cuprizone-induced demyelination in rats by modulating TNF-\u03b1\/NF-\u0138B\/NLRP3 signaling and the kynurenine pathway"],"prefix":"10.1016","volume":"999","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-3337-2969","authenticated-orcid":false,"given":"Abdelrahman M.A.","family":"Mahmoud","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manar G.","family":"Helal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"El-Sherbiny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eman","family":"Said","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manar A.","family":"Nader","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George S.G.","family":"Shehatou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejphar.2025.177686_bib1","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.taap.2015.06.005","article-title":"Cuprizone decreases intermediate and late-stage progenitor cells in hippocampal neurogenesis of rats in a framework of 28-day oral dose toxicity study","volume":"287","author":"Abe","year":"2015","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"3","key":"10.1016\/j.ejphar.2025.177686_bib2","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s12031-019-01425-6","article-title":"Neuroprotective effects of melatonin during demyelination and remyelination stages in a mouse model of multiple sclerosis","volume":"70","author":"Abo Taleb","year":"2020","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.ejphar.2025.177686_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.imu.2022.101096","article-title":"Edaravone prevents memory impairment in diabetic rats: role of oxidative stress","volume":"33","author":"Alqudah","year":"2022","journal-title":"Inform. Med. Unlocked"},{"issue":"7","key":"10.1016\/j.ejphar.2025.177686_bib4","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1007\/s00210-020-01827-z","article-title":"Edaravone protects from memory impairment induced by chronic L-methionine administration","volume":"393","author":"Alzoubi","year":"2020","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"issue":"3","key":"10.1016\/j.ejphar.2025.177686_bib5","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s10787-022-00956-6","article-title":"Neuroprotective effect of liraglutide in an experimental mouse model of multiple sclerosis: role of AMPK\/SIRT1 signaling and NLRP3 inflammasome","volume":"30","author":"Ammar","year":"2022","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.ejphar.2025.177686_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119812","article-title":"Evaluation of edaravone effects on the differentiation of human adipose derived stem cells into oligodendrocyte cells in multiple sclerosis disease in rats","volume":"282","author":"Bakhtiari","year":"2021","journal-title":"Life Sci."},{"issue":"20","key":"10.1016\/j.ejphar.2025.177686_bib7","first-page":"2711","article-title":"Cuprizone-induced demyelination in Wistar rats; electrophysiological and histological assessment","volume":"17","author":"Basoglu","year":"2013","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"13","key":"10.1016\/j.ejphar.2025.177686_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22136737","article-title":"The footprint of Kynurenine pathway in neurodegeneration: Janus-faced role in parkinson's disorder and therapeutic implications","volume":"22","author":"Behl","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.177686_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.591803","article-title":"Interplay between NLRP3 inflammasome and autophagy","volume":"11","author":"Biasizzo","year":"2020","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.ejphar.2025.177686_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/cells9061564","article-title":"Kynurenines in the pathogenesis of multiple sclerosis: therapeutic perspectives","volume":"9","author":"Biernacki","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.ejphar.2025.177686_bib11","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3389\/fnins.2014.00012","article-title":"Kynurenines in CNS disease: regulation by inflammatory cytokines","volume":"8","author":"Campbell","year":"2014","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ejphar.2025.177686_bib12","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.taap.2018.05.035","article-title":"Neuroprotective effect of linagliptin against cuprizone-induced demyelination and behavioural dysfunction in mice: a pivotal role of AMPK\/SIRT1 and JAK2\/STAT3\/NF-kappaB signalling pathway modulation","volume":"352","author":"Elbaz","year":"2018","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177686_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuro.2021.06.003","article-title":"Edaravone attenuates cadmium-induced toxicity by inhibiting oxidative stress and inflammation in ICR mice","volume":"86","author":"Fan","year":"2021","journal-title":"Neurotoxicology"},{"issue":"6","key":"10.1016\/j.ejphar.2025.177686_bib14","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1021\/acs.molpharmaceut.3c00103","article-title":"Development of edaravone ionic liquids and their application for the treatment of cerebral Ischemia\/Reperfusion injury","volume":"20","author":"Fukuta","year":"2023","journal-title":"Mol. Pharm."},{"issue":"11","key":"10.1016\/j.ejphar.2025.177686_bib15","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.4103\/1673-5374.239432","article-title":"Sequencing of high-efficacy disease-modifying therapies in multiple sclerosis: perspectives and approaches","volume":"13","author":"Grand'Maison","year":"2018","journal-title":"Neural Regen Res"},{"issue":"1","key":"10.1016\/j.ejphar.2025.177686_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-52192-8","article-title":"Role of indoleamine 2,3-dioxygenase in testicular immune-privilege","volume":"9","author":"Gualdoni","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2025.177686_bib17","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3389\/fncel.2014.00073","article-title":"Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned","volume":"8","author":"Gudi","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.ejphar.2025.177686_bib18","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ibror.2020.04.003","article-title":"Edaravone protects rat astrocytes from oxidative or neurotoxic inflammatory insults by restoring Akt\/Bcl-2\/Caspase-3 signaling axis","volume":"8","author":"Guo","year":"2020","journal-title":"IBRO Rep"},{"issue":"12","key":"10.1016\/j.ejphar.2025.177686_bib19","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.amjmed.2020.05.049","article-title":"Treatment of multiple sclerosis: a review","volume":"133","author":"Hauser","year":"2020","journal-title":"Am. J. Med."},{"issue":"2","key":"10.1016\/j.ejphar.2025.177686_bib20","doi-asserted-by":"crossref","first-page":"F354","DOI":"10.1152\/ajprenal.00408.2019","article-title":"Cyclophosphamide-induced cystitis results in NLRP3-mediated inflammation in the hippocampus and symptoms of depression in rats","volume":"318","author":"Hirshman","year":"2020","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.ejphar.2025.177686_bib21","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/B978-0-12-802395-2.00019-5","article-title":"Inflammatory demyelinating diseases of the central nervous system","volume":"145","author":"H\u00f6ftberger","year":"2017","journal-title":"Handb. Clin. Neurol."},{"issue":"6","key":"10.1016\/j.ejphar.2025.177686_bib22","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.3892\/etm.2017.4410","article-title":"Multiple sclerosis: pathology, diagnosis and treatments","volume":"13","author":"Huang","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.ejphar.2025.177686_bib23","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3389\/fimmu.2020.00388","article-title":"IDO and kynurenine metabolites in peripheral and CNS disorders","volume":"11","author":"Huang","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2025.177686_bib24","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.brainres.2017.12.035","article-title":"Free radical scavenger edaravone produces robust neuroprotection in a rat model of spinal cord injury","volume":"1682","author":"Ishii","year":"2018","journal-title":"Brain Res."},{"issue":"10","key":"10.1016\/j.ejphar.2025.177686_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/antiox9100943","article-title":"Traumatic brain injury: oxidative stress and novel anti-oxidants such as mitoquinone and edaravone","volume":"9","author":"Ismail","year":"2020","journal-title":"Antioxidants"},{"issue":"2","key":"10.1016\/j.ejphar.2025.177686_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2023.102345","article-title":"Protocol to prepare mouse spinal cord for patch-clamp and histology experiments","volume":"4","author":"Ju","year":"2023","journal-title":"STAR Protoc"},{"issue":"2","key":"10.1016\/j.ejphar.2025.177686_bib27","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/laban0211-53","article-title":"A method for removing the brain and spinal cord as one unit from adult mice and rats","volume":"40","author":"Kennedy","year":"2011","journal-title":"Lab. Anim"},{"issue":"1","key":"10.1016\/j.ejphar.2025.177686_bib28","doi-asserted-by":"crossref","DOI":"10.1111\/gbb.12663","article-title":"Cognitive disturbances in the cuprizone model of multiple sclerosis","volume":"20","author":"Kopanitsa","year":"2021","journal-title":"Gene Brain Behav."},{"issue":"5","key":"10.1016\/j.ejphar.2025.177686_bib29","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1177\/1352458514566419","article-title":"Promoting remyelination in multiple sclerosis: current drugs and future prospects","volume":"21","author":"Kremer","year":"2015","journal-title":"Mult. Scler."},{"issue":"3","key":"10.1016\/j.ejphar.2025.177686_bib30","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028936","article-title":"Multiple sclerosis pathology","volume":"8","author":"Lassmann","year":"2018","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"24","key":"10.1016\/j.ejphar.2025.177686_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232416093","article-title":"Remyelination in multiple sclerosis: findings in the cuprizone model","volume":"23","author":"Leo","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.177686_bib32","article-title":"Kynurenine pathway metabolomics predicts and provides mechanistic insight into multiple sclerosis progression","volume":"7","author":"Lim","year":"2017","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.ejphar.2025.177686_bib33","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.ejphar.2025.177686_bib34","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3389\/fimmu.2016.00246","article-title":"Current evidence for a role of the kynurenine pathway of tryptophan metabolism in multiple sclerosis","volume":"7","author":"Lovelace","year":"2016","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.ejphar.2025.177686_bib35","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1007\/s11011-023-01267-7","article-title":"Involvement of indoleamine 2, 3-dioxygenase (IDO) and brain-derived neurotrophic factor (BDNF) in the neuroprotective mechanisms of ferulic acid against depressive-like behaviour","volume":"38","author":"Mallik","year":"2023","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.ejphar.2025.177686_bib36","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.brainresbull.2021.06.006","article-title":"Treatment with edaravone improves the structure and functional changes in the hippocampus after chronic cerebral hypoperfusion in rat","volume":"174","author":"Meftahi","year":"2021","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ejphar.2025.177686_bib37","doi-asserted-by":"crossref","DOI":"10.1177\/11786469221111116","article-title":"Learning deficits induced by high-calorie feeding in the rat are associated with impaired brain Kynurenine pathway metabolism","volume":"15","author":"Mezo-Gonzalez","year":"2022","journal-title":"Int. J. Tryptophan Res."},{"issue":"1","key":"10.1016\/j.ejphar.2025.177686_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.104468","article-title":"Edaravone administration confers neuroprotection after experimental intracerebral hemorrhage in rats via NLRP3 suppression","volume":"29","author":"Miao","year":"2020","journal-title":"J. Stroke Cerebrovasc. Dis."},{"issue":"18","key":"10.1016\/j.ejphar.2025.177686_bib39","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1089\/ars.2012.5068","article-title":"Multiple sclerosis: molecular mechanisms and therapeutic opportunities","volume":"19","author":"Miljkovi\u0107","year":"2013","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.ejphar.2025.177686_bib40","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/bs.apcsb.2019.08.007","article-title":"Microglial NLRP3 inflammasome activation in multiple sclerosis","volume":"119","author":"Olcum","year":"2020","journal-title":"Adv. Protein Chem. Struct. Biol."},{"key":"10.1016\/j.ejphar.2025.177686_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102533","article-title":"Chronic fatigue and depression due to multiple sclerosis: immune-inflammatory pathways, tryptophan catabolites and the gut-brain axis as possible shared pathways","volume":"46","author":"Ormstad","year":"2020","journal-title":"Mult Scler Relat Disord"},{"issue":"2","key":"10.1016\/j.ejphar.2025.177686_bib42","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s11064-006-9165-0","article-title":"The neurotoxic effect of cuprizone on oligodendrocytes depends on the presence of pro-inflammatory cytokines secreted by microglia","volume":"32","author":"Pasquini","year":"2007","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ejphar.2025.177686_bib43","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/bs.ircmb.2016.08.003","article-title":"Mitochondria in multiple sclerosis: molecular mechanisms of pathogenesis","volume":"328","author":"Patergnani","year":"2017","journal-title":"Int Rev Cell Mol Biol"},{"key":"10.1016\/j.ejphar.2025.177686_bib44","article-title":"The IL-2 - IL-2 receptor pathway: key to understanding multiple sclerosis","volume":"4","author":"Peerlings","year":"2021","journal-title":"J Transl Autoimmun"},{"issue":"2","key":"10.1016\/j.ejphar.2025.177686_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2021.e06124","article-title":"Cuprizone markedly decreases kynurenic acid levels in the rodent brain tissue and plasma","volume":"7","author":"Polyak","year":"2021","journal-title":"Heliyon"},{"issue":"7","key":"10.1016\/j.ejphar.2025.177686_bib46","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/ejn.13543","article-title":"Edaravone attenuates intracerebroventricular streptozotocin-induced cognitive impairment in rats","volume":"45","author":"Reeta","year":"2017","journal-title":"Eur. J. Neurosci."},{"issue":"1","key":"10.1016\/j.ejphar.2025.177686_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci14010012","article-title":"Vanillic acid ameliorates demyelination in a cuprizone-induced multiple sclerosis rat model: possible underlying mechanisms","volume":"14","author":"Safwat","year":"2023","journal-title":"Brain Sci."},{"issue":"11","key":"10.1016\/j.ejphar.2025.177686_bib48","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26113423","article-title":"Neurodegeneration in multiple sclerosis: symptoms of silent progression, biomarkers and neuroprotective therapy-kynurenines are important players","volume":"26","author":"Sandi","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ejphar.2025.177686_bib49","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.neubiorev.2019.08.008","article-title":"Behavioural phenotypes in the cuprizone model of central nervous system demyelination","volume":"107","author":"Sen","year":"2019","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ejphar.2025.177686_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2021.105534","article-title":"TRPM2 contributes to neuroinflammation and cognitive deficits in a cuprizone-induced multiple sclerosis model via NLRP3 inflammasome","volume":"160","author":"Shao","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ejphar.2025.177686_bib51","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.brainres.2018.03.006","article-title":"Edaravone, a free radical scavenger, protects neuronal cells' mitochondria from ischemia by inactivating another new critical factor of the 5-lipoxygenase pathway affecting the arachidonic acid metabolism","volume":"1690","author":"Song","year":"2018","journal-title":"Brain Res."},{"issue":"12","key":"10.1016\/j.ejphar.2025.177686_bib52","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/nrneurol.2017.139","article-title":"Achievements and obstacles of remyelinating therapies in multiple sclerosis","volume":"13","author":"Stangel","year":"2017","journal-title":"Nat. Rev. Neurol."},{"issue":"1","key":"10.1016\/j.ejphar.2025.177686_bib53","doi-asserted-by":"crossref","DOI":"10.1186\/s12859-021-04344-9","article-title":"CellProfiler 4: improvements in speed, utility and usability","volume":"22","author":"Stirling","year":"2021","journal-title":"BMC Bioinf."},{"issue":"1","key":"10.1016\/j.ejphar.2025.177686_bib54","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s41592-020-01018-x","article-title":"Cellpose: a generalist algorithm for cellular segmentation","volume":"18","author":"Stringer","year":"2020","journal-title":"Nat. Methods"},{"issue":"1","key":"10.1016\/j.ejphar.2025.177686_bib55","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s12974-020-01844-y","article-title":"Kynurenine pathway modulation reverses the experimental autoimmune encephalomyelitis mouse disease progression","volume":"17","author":"Sundaram","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.ejphar.2025.177686_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.659601","article-title":"Impact of the olig family on neurodevelopmental disorders","volume":"15","author":"Szu","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ejphar.2025.177686_bib57","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.neulet.2018.01.018","article-title":"Protective effects of a radical scavenger edaravone on oligodendrocyte precursor cells against oxidative stress","volume":"668","author":"Takase","year":"2018","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2025.177686_bib58","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1600-0404.2008.01036.x","article-title":"The cuprizone model for demyelination","volume":"188","author":"Torkildsen","year":"2008","journal-title":"Acta Neurol. Scand. Suppl."},{"issue":"8","key":"10.1016\/j.ejphar.2025.177686_bib59","doi-asserted-by":"crossref","DOI":"10.3390\/genes13081324","article-title":"Nrf2\/HO-1 signaling stimulation through Acetyl-11-Keto-Beta-Boswellic acid (AKBA) provides neuroprotection in ethidium bromide-induced experimental model of multiple sclerosis","volume":"13","author":"Upadhayay","year":"2022","journal-title":"Genes"},{"issue":"2","key":"10.1016\/j.ejphar.2025.177686_bib60","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2174\/1570159X15666170717120343","article-title":"Five decades of cuprizone, an updated model to replicate demyelinating diseases","volume":"17","author":"Vega-Riquer","year":"2019","journal-title":"Curr. Neuropharmacol."},{"issue":"3","key":"10.1016\/j.ejphar.2025.177686_bib61","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1037\/0033-2909.83.3.482","article-title":"The open-field test: a critical review","volume":"83","author":"Walsh","year":"1976","journal-title":"Psychol. Bull."},{"issue":"14","key":"10.1016\/j.ejphar.2025.177686_bib62","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1177\/1352458520970841","article-title":"Rising prevalence of multiple sclerosis worldwide: insights from the Atlas of MS, third edition","volume":"26","author":"Walton","year":"2020","journal-title":"Mult. Scler."},{"issue":"1","key":"10.1016\/j.ejphar.2025.177686_bib63","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ijpharm.2018.06.068","article-title":"Edaravone, a cytoprotective drug, enhances transgene expression mediated by lipoplexes in HepG2 cells and mice","volume":"548","author":"Wang","year":"2018","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.ejphar.2025.177686_bib64","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1159\/000487031","article-title":"Neuroprotective mechanisms of calycosin against focal cerebral ischemia and reperfusion injury in rats","volume":"45","author":"Wang","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"issue":"8","key":"10.1016\/j.ejphar.2025.177686_bib65","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.2174\/1381612822666151215095940","article-title":"Tryptophan catabolites and their impact on multiple sclerosis progression","volume":"22","author":"Watzlawik","year":"2016","journal-title":"Curr. Pharm. Des."},{"issue":"5","key":"10.1016\/j.ejphar.2025.177686_bib66","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25052945","article-title":"Update on antioxidant therapy with edaravone: expanding applications in neurodegenerative diseases","volume":"25","author":"Yamashita","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.ejphar.2025.177686_bib67","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3389\/neuro.01.029.2008","article-title":"Light phase testing of social behaviors: not a problem","volume":"2","author":"Yang","year":"2008","journal-title":"Front. Neurosci."},{"issue":"11","key":"10.1016\/j.ejphar.2025.177686_bib68","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1007\/s10072-015-2314-y","article-title":"Edaravone injection ameliorates cognitive deficits in rat model of Alzheimer's disease","volume":"36","author":"Yang","year":"2015","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.ejphar.2025.177686_bib69","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s12868-014-0125-3","article-title":"Anti-inflammatory effects of Edaravone and Scutellarin in activated microglia in experimentally induced ischemia injury in rats and in BV-2 microglia","volume":"15","author":"Yuan","year":"2014","journal-title":"BMC Neurosci."},{"issue":"11","key":"10.1016\/j.ejphar.2025.177686_bib70","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1111\/ejn.15016","article-title":"Regulation of indoleamine 2, 3-dioxygenase in hippocampal microglia by NLRP3 inflammasome in lipopolysaccharide-induced depressive-like behaviors","volume":"52","author":"Zhang","year":"2020","journal-title":"Eur. J. Neurosci."},{"issue":"4","key":"10.1016\/j.ejphar.2025.177686_bib71","doi-asserted-by":"crossref","DOI":"10.1177\/1759091417725174","article-title":"An alternative cuprizone-induced demyelination and remyelination mouse model","volume":"9","author":"Zhen","year":"2017","journal-title":"ASN Neuro"},{"issue":"1","key":"10.1016\/j.ejphar.2025.177686_bib72","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13024-022-00538-8","article-title":"Oligodendrocyte death and myelin loss in the cuprizone model: an updated overview of the intrinsic and extrinsic causes of cuprizone demyelination","volume":"17","author":"Zirngibl","year":"2022","journal-title":"Mol. Neurodegener."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925004406?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925004406?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T16:07:03Z","timestamp":1750435623000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299925004406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":72,"alternative-id":["S0014299925004406"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177686","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Edaravone protects against cuprizone-induced demyelination in rats by modulating TNF-\u03b1\/NF-\u0138B\/NLRP3 signaling and the kynurenine pathway","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177686","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"177686"}}